Named Patient Management Services and Programs

Navigating access to unapproved or pre-launch therapies requires precision, compliance, and a trusted supply partner. VuRoyal Pharmaceutical provides end-to-end named patient management services—connecting patients and healthcare providers with safe, verified pharmaceutical substances through fully compliant procurement, regulatory support, and specialty logistics.

Pharmaceutical specialist coordinating named patient program access for a healthcare provider

Our Named Patient Management Services

Comprehensive patient access solutions spanning referrals, specialty drug sourcing, distribution, and end-to-end regulatory support.

Patient Referral Services

VuRoyal connects eligible patients with reputable healthcare systems, physicians, and hospitals, accelerating access to appropriate therapies and clinical programs through trusted referral partnerships.

Specialty Drug Sourcing

We procure FDA Orange/Purple Book reference drugs and hard-to-source pharmaceutical substances globally, ensuring research-grade quality and full regulatory compliance for named patient access needs.

Distribution to Care Settings

VuRoyal's advanced logistics network delivers specialty pharmaceuticals to hospitals, clinics, independent pharmacies, and alternative care settings with cold chain capabilities and timely precision.

Pharmaceutical logistics team managing specialty drug packaging and cold chain delivery for a named patient program

Our 5-Step Named Patient Access Process

Patient Eligibility & Needs Assessment

We begin by reviewing the patient's medical situation and therapy requirements with the referring healthcare provider or sponsor, identifying the most appropriate named patient or compassionate use pathway available.

Regulatory Strategy & Filing Support

Global Sourcing & Procurement

Specialty Logistics & Cold Chain Delivery

Ongoing Support & Patient Referral Coordination

The VuRoyal Difference

Why Choose VuRoyal Pharmaceutical?

VuRoyal combines decades of pharmaceutical R&D experience with a fully compliant global supply chain to deliver named patient programs with unmatched reliability.

Regulatory Expertise

FDA-registered and Massachusetts-licensed, we provide free regulatory guidance covering import approval, filing, and end-to-end compliance.

Global Sourcing

Our verified global procurement network sources rare and specialty pharmaceuticals from compliant international suppliers with full documentation.

Verified Quality

Every substance is sourced through compliance-verified partnerships with drug business quality management certification, ensuring patient safety above all.

Single-Source Simplicity

From regulatory filing and international procurement to customs clearance and cold chain delivery, VuRoyal is your one partner for the entire process.

Meet the VuRoyal Team

Experienced pharmaceutical professionals dedicated to advancing patient access globally.

Headshot of Hao Wang, Chief Executive Officer

Hao Wang

Chief Executive Officer, Ph.D., MPA

Hao Wang, Ph.D., MPA, leads VuRoyal Pharmaceutical as Chief Executive Officer, bringing decades of expertise at the intersection of pharmaceutical science, regulatory affairs, and global supply chain management. A recognized voice in the vaccine adjuvant industry, Dr. Wang has moderated high-profile scientific forums on GMP-grade adjuvant technology — including VuRoyal's inaugural QS-21 Forum in Shanghai in March 2024 and the 2nd Online Technology Forum on Novel Vaccine Adjuvants in April 2025. Under his leadership, VuRoyal secured its exclusive partnership with Desert King International in China, achieved multiple regulatory milestones including pharmaceutical excipient registration in China, and established the company as a trusted FDA-registered pharmaceutical wholesaler operating from Boston with a truly global reach. Dr. Wang's vision centers on making safe, genuine, and compliant pharmaceutical substances reliably accessible to logistics companies, research sponsors, and healthcare providers worldwide.

Frequently Asked Questions

What is a named patient program?

A named patient program (NPP) is a regulatory mechanism that allows physicians to access unapproved or pre-launch medicines for a specific, identified patient when no satisfactory alternative treatment is available. These programs operate outside standard marketing authorization and require regulatory approval, proper documentation, and a compliant supply chain to source and deliver the required therapy safely and legally.

What is patient management in healthcare?

Who is eligible for a named patient program?

Can VuRoyal supply medications directly to individual patients?

What types of organizations does VuRoyal support through named patient programs?

How does VuRoyal ensure regulatory compliance in named patient drug sourcing?

Does VuRoyal offer cold chain transportation for named patient medicines?

Is there a consultation fee for named patient program regulatory guidance?

Still Have Questions About Named Patient Access?

Speak directly with our pharmaceutical access specialists for a free, no-obligation consultation.

Certified & Trusted

Awards and Recognition

FDA registered pharmaceutical wholesaler certification badge

FDA-Registered Wholesaler

Recognized as a compliant, federally registered pharmaceutical wholesaler.

Drug business quality management standard certification badge

Drug Business Quality Management

Certified under drug business quality management standards for safe distribution.

Massachusetts approved pharmaceutical wholesaler license badge

Massachusetts-Approved Distributor

State-licensed pharmaceutical wholesaler and exporter approved in Massachusetts.

Request Named Patient Program Support

Complete the form below and a VuRoyal specialist will reach out to discuss your named patient access needs, regulatory requirements, and sourcing options—at no cost to you.

Contact Us Today

For immediate assistance, feel free to give us a direct call at +1 617-870-2690.